Found: 11
Select item for more details and to access through your institution.
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Flow Cytometry Assessment of CD26<sup>+</sup> Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia.
- Published in:
- Cytometry. Part B, 2019, v. 96, n. 4, p. 294, doi. 10.1002/cyto.b.21764
- By:
- Publication type:
- Article
p57Kip2 is a downstream effector of BCR–ABL kinase inhibitors in chronic myelogenous leukemia cells.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 1, p. 10, doi. 10.1093/carcin/bgq211
- By:
- Publication type:
- Article
Impact of Arterial Thrombotic Events on the Outcome of Chronic Myeloid Leukemia Patients Treated with Nilotinib First-Line: A GIMEMA CML WP Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S313, doi. 10.1016/j.clml.2017.07.114
- By:
- Publication type:
- Article
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 797, doi. 10.1002/ajh.24774
- By:
- Publication type:
- Article
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 617, doi. 10.1002/ajh.24362
- By:
- Publication type:
- Article
Reproducibility of liver iron concentration measured on a biopsy sample: A validation study in vivo.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 87, doi. 10.1002/ajh.23878
- By:
- Publication type:
- Article
Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 12, p. 960, doi. 10.1002/ajh.21871
- By:
- Publication type:
- Article
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 10, p. 636, doi. 10.1002/ajh.21504
- By:
- Publication type:
- Article
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04462-8
- By:
- Publication type:
- Article